Ģ����ý

Ģ����ý�For a highly developed company like Ģ����ý, enhancements to products typically involve significant opportunities,Ģ����ý� explains de Wit. Ģ����ý�In China, things are a little different. Here is demand in all areas, from the local infrastructure and the question of how to provide the best possible care for patients, even in remote areas, to the scalability of products and services in the face of steadily growing demand.Ģ����ý� After all, the number of patients with chronic kidney failure in China is rising particularly fast, even compared to other Asian countries, at over ten percent per year. Ģ����ý�In the last ten years, China has probably made greater progress in dialysis care than the rest of the world put together. That, combined with a steadily growing middle class, gives us good reason to look to the future with optimism. We benefit from the populationĢ����ý�s growing demands on the health care system in their country and the fact that more and more people not only want access to better health care provision, but can also afford it.Ģ����ý�

When David Grier and Andrew Stuart, two South African endurance athletes, were planning their 4,200-kilometer run��along the Great Wall of China, Ģ����ý came on board as a partner. It seemed like an ideal opportunity to draw attention to the topic of kidney health over a period of several weeks. And it paid off: The run became a nationwide event, reaching more than 300 million people, above all thanks to social media.

China is undergoing a process of profound change. The country is opening up in the health care sector also to foreign companies. In the past two years, Ģ����ý has achieved several milestones in China. In late 2017, the first renal hospital specializing in chronic-disease management and hemodialysis was opened as a joint venture. Shortly afterwards, Ģ����ý announced the acquisition of its first independent dialysis center in Quanzhou.

This was followed by further acquisitions in 2018, including two 70 percent stakes in hospitals in Sichuan Province and the addition of several renal hospitals and dialysis centers. The pipeline is well filled with more than 20 sites Ģ����ý� for good reason: Ģ����ý�We expect the Chinese government to issue further approvals for renal hospitals and dialysis centers over the coming years, and have prepared ourselves for this development,Ģ����ý� explains de Wit.

Ģ����ý is also focusing on expanding its research and development activities. In 2015, it established a proprietary Ģ����ý�China Design CenterĢ����ý� in Shanghai, which supplements the development work of the production site in Changshu that the Company acquired in 2007 and is in close contact with the product development team in Schweinfurt.